USPTO serial 99327850
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Keith Toms, Esq.
Keith Toms, Esq. McCarter & English265 Franklin StreetBoston, MA 02110United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations; Pharmaceutical preparations for the treatment of Cystic Fibrosis; Pharmaceutical preparations for the treatment of genetic diseases or disorders; Pharmaceutical preparations for the treatment of endocrine diseases or disorders; Pharmaceutical preparations for the treatment of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disorders | ACTIVE | — |
| 042 | Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; Consulting services for others in the field of pharmaceutical research and development; Consulting services for others in the field of pharmaceuticals; Research and development in the field of Cystic Fibrosis; Research and development in the field of genetic diseases or disorders; Research and development in the field of endocrine diseases or disorders; Research and development in the field of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disorders | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 30, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 30, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 23, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 23, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 8, 2025 | NWAP | NEW APPLICATION ENTERED | — |